Gary Bryan Hendler
Corporate Officer/Principal chez EISAI CO., LTD.
Profil
Gary Bryan Hendler currently works at Eisai Ltd.
(United Kingdom), as Chairman & Chief Executive Officer from 2016, Eisai Farmacéutica SA, as Chairman & Chief Executive Officer from 2020, Eisai SAS, as Chairman, Eisai GmbH, as Co-Managing Director, and Eisai Co., Ltd., as Managing Executive Officer & President-EMEA from 2016.
Postes actifs de Gary Bryan Hendler
| Sociétés | Poste | Début |
|---|---|---|
| EISAI CO., LTD. | Corporate Officer/Principal | 01/06/2010 |
Eisai Ltd. (United Kingdom)
 Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Chief Executive Officer | 01/04/2016 |
Eisai GmbH
 Eisai GmbH Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai GmbH is a German pharmaceutical company that specializes in research and development of innovative treatments for neurological and oncological diseases. The private company is based in Frankfurt, Germany. The CEOs of the company are Gary Bryan Hendler, Nicholas Conrad Burgin. | Chief Executive Officer | - |
Eisai SAS
 Eisai SAS Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai SAS is a French pharmaceutical company founded in 1996. The private company is based in Courbevoie, France and strives to improve the lives of those who could benefit from their medicines. Eisai focuses its research on oncology and neurology, two areas presenting challenges in terms of public health. The company is committed to the fight against serious diseases, alongside patients, healthcare professionals, and public authorities. | Chairman | - |
Eisai Farmacéutica SA
 Eisai Farmacéutica SA Pharmaceuticals: MajorHealth Technology Eisai Farmacéutica SA is a pharmaceutical company based in Madrid, Spain. Eisai Farmacéutica SA operates as a Spanish pharmaceutical company. Part of Eisai Co., Ltd., the private company was founded in 2001. The CEO is Gary Bryan Hendler. | Chief Executive Officer | 29/12/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EISAI CO., LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Eisai Ltd. (United Kingdom)
Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Health Technology |
Eisai SAS
Eisai SAS Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai SAS is a French pharmaceutical company founded in 1996. The private company is based in Courbevoie, France and strives to improve the lives of those who could benefit from their medicines. Eisai focuses its research on oncology and neurology, two areas presenting challenges in terms of public health. The company is committed to the fight against serious diseases, alongside patients, healthcare professionals, and public authorities. | Health Technology |
Eisai Farmacéutica SA
Eisai Farmacéutica SA Pharmaceuticals: MajorHealth Technology Eisai Farmacéutica SA is a pharmaceutical company based in Madrid, Spain. Eisai Farmacéutica SA operates as a Spanish pharmaceutical company. Part of Eisai Co., Ltd., the private company was founded in 2001. The CEO is Gary Bryan Hendler. | Health Technology |
Eisai GmbH
Eisai GmbH Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai GmbH is a German pharmaceutical company that specializes in research and development of innovative treatments for neurological and oncological diseases. The private company is based in Frankfurt, Germany. The CEOs of the company are Gary Bryan Hendler, Nicholas Conrad Burgin. | Health Technology |
